24 May 2013
Keywords: protein, thera, starts, juvenile, ra, study, therapeutics
Article | 13 July 2001
Protein Therapeutics has started a Phase II trial of its oral humangammaglobulin product, IgPO, in patients with severe juvenile rheumatoid
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 July 2001
11 July 2001
23 May 2013
© 2013 thepharmaletter.com